News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Policy
Albany Molecular Research, Inc.; Sanofi-Aventis (France) Seeks Injunction Against Dr. Reddy’s Laboratories Ltd.'s
March 24, 2010
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
Reuters -- Albany Molecular Research Inc (AMRI.O) along with Sanofi Aventis SA's (SASY.PA) U.S. unit sought a preliminary injunction against India's Dr Reddy's Laboratories Ltd (REDY.BO) from distributing a copycat version of allergy drug Allegra-D.
Twitter
LinkedIn
Facebook
Email
Print
Legal
Sanofi
MORE ON THIS TOPIC
Patents
Pfizer settles with generic drugmakers to protect blockbuster drug until 2031
April 29, 2026
·
2 min read
·
Nick Paul Taylor
Pancreatic cancer
Revolution levels legal threat on Erasca as pancreatic cancer rivalry heats up
April 28, 2026
·
3 min read
·
Tristan Manalac
Drug pricing
Regeneron finally joins Trump’s drug pricing push while notching landmark approval
April 24, 2026
·
2 min read
·
Tristan Manalac
Complete response letters
Unnamed pharma files citizen petition targeting FDA’s trove of rejection letters
April 23, 2026
·
2 min read
·
Tristan Manalac